Synthesis	O
of	O
4	B:C1254351
(	I:C1254351
3H	I:C1254351
)	I:C1254351
quinazolinimines	I:C1254351
with	O
selective	O
cytotoxic	I:C0596402
effect	I:C0596402
on	O
human	O
acute	O
promyelocytic	I:C0023487
leukemia	I:C0023487
cells	O

Synthesis	O
of	O
4	O
(	I:C1254351
3H	I:C1254351
)	I:C1254351
quinazolinimines	I:C1254351
with	O
selective	B:C0596402
cytotoxic	I:C0596402
effect	I:C0596402
on	O
human	O
acute	O
promyelocytic	I:C0023487
leukemia	I:C0023487
cells	O

Synthesis	O
of	O
4	O
(	I:C1254351
3H	I:C1254351
)	I:C1254351
quinazolinimines	I:C1254351
with	O
selective	O
cytotoxic	I:C0596402
effect	I:C0596402
on	O
human	O
acute	B:C0023487
promyelocytic	I:C0023487
leukemia	I:C0023487
cells	O

Synthesis	O
of	O
4	O
(	I:C1254351
3H	I:C1254351
)	I:C1254351
quinazolinimines	I:C1254351
with	O
selective	O
cytotoxic	I:C0596402
effect	I:C0596402
on	O
human	O
acute	O
promyelocytic	I:C0023487
leukemia	I:C0023487
cells	B:C0007634

We	O
synthesized	O
a	O
new	O
family	O
of	O
six	O
4	B:C0034407
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
based	O
on	O
the	O
reaction	O
between	O
(	O
E	I:C0029224
)	I:C0029224
-	I:C0029224
N	I:C0029224
-	I:C0029224
(	I:C0029224
2	I:C0029224
-	I:C0029224
cyanophenyl	I:C0029224
)	I:C0029224
benzimidoyl	I:C0029224
chloride	I:C0029224
and	O
substituted	O
anilines	I:C0003038
reaching	O
the	O
formation	O
of	O
their	O
corresponding	O
C2	O
,	I:C1254351
N3	I:C1254351
-	I:C1254351
substituted	I:C1254351
quinazoliniminium	I:C1254351
chlorides	I:C1254351
.	O

We	O
synthesized	O
a	O
new	O
family	O
of	O
six	O
4	O
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
based	O
on	O
the	O
reaction	O
between	O
(	B:C0029224
E	I:C0029224
)	I:C0029224
-	I:C0029224
N	I:C0029224
-	I:C0029224
(	I:C0029224
2	I:C0029224
-	I:C0029224
cyanophenyl	I:C0029224
)	I:C0029224
benzimidoyl	I:C0029224
chloride	I:C0029224
and	O
substituted	O
anilines	I:C0003038
reaching	O
the	O
formation	O
of	O
their	O
corresponding	O
C2	O
,	I:C1254351
N3	I:C1254351
-	I:C1254351
substituted	I:C1254351
quinazoliniminium	I:C1254351
chlorides	I:C1254351
.	O

We	O
synthesized	O
a	O
new	O
family	O
of	O
six	O
4	O
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
based	O
on	O
the	O
reaction	O
between	O
(	O
E	I:C0029224
)	I:C0029224
-	I:C0029224
N	I:C0029224
-	I:C0029224
(	I:C0029224
2	I:C0029224
-	I:C0029224
cyanophenyl	I:C0029224
)	I:C0029224
benzimidoyl	I:C0029224
chloride	I:C0029224
and	O
substituted	B:C0003038
anilines	I:C0003038
reaching	O
the	O
formation	O
of	O
their	O
corresponding	O
C2	O
,	I:C1254351
N3	I:C1254351
-	I:C1254351
substituted	I:C1254351
quinazoliniminium	I:C1254351
chlorides	I:C1254351
.	O

We	O
synthesized	O
a	O
new	O
family	O
of	O
six	O
4	O
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
based	O
on	O
the	O
reaction	O
between	O
(	O
E	I:C0029224
)	I:C0029224
-	I:C0029224
N	I:C0029224
-	I:C0029224
(	I:C0029224
2	I:C0029224
-	I:C0029224
cyanophenyl	I:C0029224
)	I:C0029224
benzimidoyl	I:C0029224
chloride	I:C0029224
and	O
substituted	O
anilines	I:C0003038
reaching	O
the	O
formation	O
of	O
their	O
corresponding	O
C2	B:C1254351
,	I:C1254351
N3	I:C1254351
-	I:C1254351
substituted	I:C1254351
quinazoliniminium	I:C1254351
chlorides	I:C1254351
.	O

This	O
method	O
provides	O
novel	O
,	O
direct	O
and	O
flexible	O
access	O
to	O
diverse	O
substituted	O
4	B:C1254351
(	I:C1254351
3H	I:C1254351
)	I:C1254351
quinazolinimines	I:C1254351
.	O

New	O
compounds	B:C1706082
obtained	O
following	O
the	O
proposed	O
synthesis	O
were	O
fully	O
characterized	O
and	O
,	O
including	O
the	O
thirteen	O
4	O
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
synthesized	O
by	O
this	O
method	O
and	O
previously	O
reported	I:C0023866
by	O
us	O
,	O
were	O
used	O
to	O
study	O
its	O
cytotoxic	O
effect	I:C0596402
on	O
neoplastic	O
cell	I:C0597032
lines	I:C0597032
.	O

New	O
compounds	O
obtained	O
following	O
the	O
proposed	O
synthesis	O
were	O
fully	O
characterized	O
and	O
,	O
including	O
the	O
thirteen	O
4	B:C0034407
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
synthesized	O
by	O
this	O
method	O
and	O
previously	O
reported	I:C0023866
by	O
us	O
,	O
were	O
used	O
to	O
study	O
its	O
cytotoxic	O
effect	I:C0596402
on	O
neoplastic	O
cell	I:C0597032
lines	I:C0597032
.	O

New	O
compounds	O
obtained	O
following	O
the	O
proposed	O
synthesis	O
were	O
fully	O
characterized	O
and	O
,	O
including	O
the	O
thirteen	O
4	O
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
synthesized	O
by	O
this	O
method	O
and	O
previously	B:C0023866
reported	I:C0023866
by	O
us	O
,	O
were	O
used	O
to	O
study	O
its	O
cytotoxic	O
effect	I:C0596402
on	O
neoplastic	O
cell	I:C0597032
lines	I:C0597032
.	O

New	O
compounds	O
obtained	O
following	O
the	O
proposed	O
synthesis	O
were	O
fully	O
characterized	O
and	O
,	O
including	O
the	O
thirteen	O
4	O
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
synthesized	O
by	O
this	O
method	O
and	O
previously	O
reported	I:C0023866
by	O
us	O
,	O
were	O
used	O
to	O
study	B:C0008972
its	O
cytotoxic	O
effect	I:C0596402
on	O
neoplastic	O
cell	I:C0597032
lines	I:C0597032
.	O

New	O
compounds	O
obtained	O
following	O
the	O
proposed	O
synthesis	O
were	O
fully	O
characterized	O
and	O
,	O
including	O
the	O
thirteen	O
4	O
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
synthesized	O
by	O
this	O
method	O
and	O
previously	O
reported	I:C0023866
by	O
us	O
,	O
were	O
used	O
to	O
study	O
its	O
cytotoxic	B:C0596402
effect	I:C0596402
on	O
neoplastic	O
cell	I:C0597032
lines	I:C0597032
.	O

New	O
compounds	O
obtained	O
following	O
the	O
proposed	O
synthesis	O
were	O
fully	O
characterized	O
and	O
,	O
including	O
the	O
thirteen	O
4	O
(	I:C0034407
3H	I:C0034407
)	I:C0034407
quinazolinimines	I:C0034407
synthesized	O
by	O
this	O
method	O
and	O
previously	O
reported	I:C0023866
by	O
us	O
,	O
were	O
used	O
to	O
study	O
its	O
cytotoxic	O
effect	I:C0596402
on	O
neoplastic	B:C0597032
cell	I:C0597032
lines	I:C0597032
.	O

The	O
mechanism	O
involved	O
in	O
cell	B:C0596402
toxicity	I:C0596402
was	O
also	O
studied	O
.	O

The	O
mechanism	O
involved	O
in	O
cell	O
toxicity	I:C0596402
was	O
also	O
studied	B:C0008972
.	O

Results	O
showed	O
that	O
these	O
compounds	B:C1706082
were	O
highly	O
cytotoxic	O
,	O
in	O
particular	O
on	O
Human	O
Promyelocytic	I:C0282549
Leukemia	I:C0282549
cells	I:C0282549
(	O
HL60	O
)	O
and	O
Chronic	O
Myelogenous	I:C0600432
Leukemia	I:C0600432
cells	I:C0600432
(	O
K562	O
)	O
when	O
compared	O
with	O
conventional	O
antineoplastic	O
drugs	I:C0003392
such	O
as	O
etoposide	O
and	O
cisplatin	O
.	O

Results	O
showed	O
that	O
these	O
compounds	O
were	O
highly	O
cytotoxic	O
,	O
in	O
particular	O
on	O
Human	B:C0282549
Promyelocytic	I:C0282549
Leukemia	I:C0282549
cells	I:C0282549
(	O
HL60	O
)	O
and	O
Chronic	O
Myelogenous	I:C0600432
Leukemia	I:C0600432
cells	I:C0600432
(	O
K562	O
)	O
when	O
compared	O
with	O
conventional	O
antineoplastic	O
drugs	I:C0003392
such	O
as	O
etoposide	O
and	O
cisplatin	O
.	O

Results	O
showed	O
that	O
these	O
compounds	O
were	O
highly	O
cytotoxic	O
,	O
in	O
particular	O
on	O
Human	O
Promyelocytic	I:C0282549
Leukemia	I:C0282549
cells	I:C0282549
(	O
HL60	B:C0282549
)	O
and	O
Chronic	O
Myelogenous	I:C0600432
Leukemia	I:C0600432
cells	I:C0600432
(	O
K562	O
)	O
when	O
compared	O
with	O
conventional	O
antineoplastic	O
drugs	I:C0003392
such	O
as	O
etoposide	O
and	O
cisplatin	O
.	O

Results	O
showed	O
that	O
these	O
compounds	O
were	O
highly	O
cytotoxic	O
,	O
in	O
particular	O
on	O
Human	O
Promyelocytic	I:C0282549
Leukemia	I:C0282549
cells	I:C0282549
(	O
HL60	O
)	O
and	O
Chronic	B:C0600432
Myelogenous	I:C0600432
Leukemia	I:C0600432
cells	I:C0600432
(	O
K562	O
)	O
when	O
compared	O
with	O
conventional	O
antineoplastic	O
drugs	I:C0003392
such	O
as	O
etoposide	O
and	O
cisplatin	O
.	O

Results	O
showed	O
that	O
these	O
compounds	O
were	O
highly	O
cytotoxic	O
,	O
in	O
particular	O
on	O
Human	O
Promyelocytic	I:C0282549
Leukemia	I:C0282549
cells	I:C0282549
(	O
HL60	O
)	O
and	O
Chronic	O
Myelogenous	I:C0600432
Leukemia	I:C0600432
cells	I:C0600432
(	O
K562	B:C0600432
)	O
when	O
compared	O
with	O
conventional	O
antineoplastic	O
drugs	I:C0003392
such	O
as	O
etoposide	O
and	O
cisplatin	O
.	O

Results	O
showed	O
that	O
these	O
compounds	O
were	O
highly	O
cytotoxic	O
,	O
in	O
particular	O
on	O
Human	O
Promyelocytic	I:C0282549
Leukemia	I:C0282549
cells	I:C0282549
(	O
HL60	O
)	O
and	O
Chronic	O
Myelogenous	I:C0600432
Leukemia	I:C0600432
cells	I:C0600432
(	O
K562	O
)	O
when	O
compared	O
with	O
conventional	O
antineoplastic	B:C0003392
drugs	I:C0003392
such	O
as	O
etoposide	O
and	O
cisplatin	O
.	O

Results	O
showed	O
that	O
these	O
compounds	O
were	O
highly	O
cytotoxic	O
,	O
in	O
particular	O
on	O
Human	O
Promyelocytic	I:C0282549
Leukemia	I:C0282549
cells	I:C0282549
(	O
HL60	O
)	O
and	O
Chronic	O
Myelogenous	I:C0600432
Leukemia	I:C0600432
cells	I:C0600432
(	O
K562	O
)	O
when	O
compared	O
with	O
conventional	O
antineoplastic	O
drugs	I:C0003392
such	O
as	O
etoposide	B:C0015133
and	O
cisplatin	O
.	O

Results	O
showed	O
that	O
these	O
compounds	O
were	O
highly	O
cytotoxic	O
,	O
in	O
particular	O
on	O
Human	O
Promyelocytic	I:C0282549
Leukemia	I:C0282549
cells	I:C0282549
(	O
HL60	O
)	O
and	O
Chronic	O
Myelogenous	I:C0600432
Leukemia	I:C0600432
cells	I:C0600432
(	O
K562	O
)	O
when	O
compared	O
with	O
conventional	O
antineoplastic	O
drugs	I:C0003392
such	O
as	O
etoposide	O
and	O
cisplatin	B:C0008838
.	O

The	O
mechanism	O
associated	O
to	O
cytotoxic	B:C0596402
effect	I:C0596402
was	O
mainly	O
apoptosis	O
,	O
which	O
not	O
was	O
decreased	O
by	O
antioxidant	O
addition	O
,	O
thereby	O
suggesting	O
that	O
the	O
compounds	O
exert	O
apoptotic	O
death	I:C0162638
through	O
a	O
mechanism	O
unrelated	O
with	O
oxidative	O
stress	I:C0242606
.	O

The	O
mechanism	O
associated	O
to	O
cytotoxic	O
effect	I:C0596402
was	O
mainly	O
apoptosis	B:C0162638
,	O
which	O
not	O
was	O
decreased	O
by	O
antioxidant	O
addition	O
,	O
thereby	O
suggesting	O
that	O
the	O
compounds	O
exert	O
apoptotic	O
death	I:C0162638
through	O
a	O
mechanism	O
unrelated	O
with	O
oxidative	O
stress	I:C0242606
.	O

The	O
mechanism	O
associated	O
to	O
cytotoxic	O
effect	I:C0596402
was	O
mainly	O
apoptosis	O
,	O
which	O
not	O
was	O
decreased	O
by	O
antioxidant	B:C0003402
addition	O
,	O
thereby	O
suggesting	O
that	O
the	O
compounds	O
exert	O
apoptotic	O
death	I:C0162638
through	O
a	O
mechanism	O
unrelated	O
with	O
oxidative	O
stress	I:C0242606
.	O

The	O
mechanism	O
associated	O
to	O
cytotoxic	O
effect	I:C0596402
was	O
mainly	O
apoptosis	O
,	O
which	O
not	O
was	O
decreased	O
by	O
antioxidant	O
addition	O
,	O
thereby	O
suggesting	O
that	O
the	O
compounds	B:C1254351
exert	O
apoptotic	O
death	I:C0162638
through	O
a	O
mechanism	O
unrelated	O
with	O
oxidative	O
stress	I:C0242606
.	O

The	O
mechanism	O
associated	O
to	O
cytotoxic	O
effect	I:C0596402
was	O
mainly	O
apoptosis	O
,	O
which	O
not	O
was	O
decreased	O
by	O
antioxidant	O
addition	O
,	O
thereby	O
suggesting	O
that	O
the	O
compounds	O
exert	O
apoptotic	B:C0162638
death	I:C0162638
through	O
a	O
mechanism	O
unrelated	O
with	O
oxidative	O
stress	I:C0242606
.	O

The	O
mechanism	O
associated	O
to	O
cytotoxic	O
effect	I:C0596402
was	O
mainly	O
apoptosis	O
,	O
which	O
not	O
was	O
decreased	O
by	O
antioxidant	O
addition	O
,	O
thereby	O
suggesting	O
that	O
the	O
compounds	O
exert	O
apoptotic	O
death	I:C0162638
through	O
a	O
mechanism	O
unrelated	B:C0445356
with	O
oxidative	O
stress	I:C0242606
.	O

The	O
mechanism	O
associated	O
to	O
cytotoxic	O
effect	I:C0596402
was	O
mainly	O
apoptosis	O
,	O
which	O
not	O
was	O
decreased	O
by	O
antioxidant	O
addition	O
,	O
thereby	O
suggesting	O
that	O
the	O
compounds	O
exert	O
apoptotic	O
death	I:C0162638
through	O
a	O
mechanism	O
unrelated	O
with	O
oxidative	B:C0242606
stress	I:C0242606
.	O

